Skip to main content
You have permission to edit this article.
Edit

One company settles, another loses lawsuit over roles in opioid crisis

  • Updated
  • 0
One company settles, another loses lawsuit over roles in opioid crisis

NEW YORK (AP) - Pharmaceutical company Allergan Finance LLC will pay $200 million to New York state and two of its counties as part of an agreement that removes it from an ongoing state lawsuit over the opioid crisis.

In the agreement, Allergan did not admit to any liability. In a statement, the company said it was “pleased” to have reached the settlement.

Also, a jury has held Teva Pharmaceuticals responsible for contributing to the opioid crisis. Jurors delivered their verdict Thursday in a sweeping lawsuit filed by New York state and joined by two Long Island counties.

The Suffolk County jury found the company played a role in furthering a public nuisance.

Teva is known for making generic drugs, but the lawsuit focused on the brand-name fentanyl drugs Actiq and Fentora. They are approved for some cancer patients. The lawsuit accused Teva of repeatedly promoting them more broadly for other types of pain.

Teva says it strongly disagrees with the verdict and plans to appeal.

(Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.)

Recommended for you